AnaptysBio, Inc.
AnaptysBio, Inc. (ANAB) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · ANAB · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
46
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
AnaptysBio, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
ANAB insider buying and selling by quarter
ANAB insider selling · ANAB insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · ANAB ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
ANAB executive sell shares · ANAB board member insider trading · ANAB insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Mar 30, 2026 | Schmid John P. Director | Sale | 12,596 | $702K | Form 4 |
| Mar 30, 2026 | Schmid John P. Director | Sale | 7,527 | $427K | Form 4 |
| Mar 30, 2026 | Schmid John P. Director | Sale | 522 | $30K | Form 4 |
| Mar 25, 2026 | Faga Daniel President, CEO · Director | Award | 34,300 | — | Form 4 |
| Mar 27, 2026 | Faga Daniel President, CEO · Director | Sale | 510 | $29K | Form 4 |
| Mar 27, 2026 | Faga Daniel President, CEO · Director | Sale | 2,570 | $149K | Form 4 |
| Mar 27, 2026 | Faga Daniel President, CEO · Director | Sale | 3,662 | $215K | Form 4 |
| Mar 27, 2026 | Faga Daniel President, CEO · Director | Sale | 490 | $29K | Form 4 |
| Mar 27, 2026 | Faga Daniel President, CEO · Director | Sale | 550 | $33K | Form 4 |
| Mar 27, 2026 | Faga Daniel President, CEO · Director | Sale | 1,012 | $63K | Form 4 |
| Mar 27, 2026 | Faga Daniel President, CEO · Director | Sale | 2,592 | $164K | Form 4 |
| Mar 27, 2026 | Faga Daniel President, CEO · Director | Sale | 3,155 | $203K | Form 4 |
| Mar 27, 2026 | Faga Daniel President, CEO · Director | Sale | 3,038 | $198K | Form 4 |
| Mar 27, 2026 | Faga Daniel President, CEO · Director | Sale | 100 | $7K | Form 4 |
| Feb 11, 2026 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Option | 10,000 | $297K | Form 4 |
| Feb 11, 2026 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Sale | 10,000 | $540K | Form 4 |
| Jan 15, 2026 | Marquet Magda Director | Option | 11,000 | $287K | Form 4 |
| Jan 15, 2026 | Marquet Magda Director | Sale | 9,290 | $447K | Form 4 |
| Jan 15, 2026 | Marquet Magda Director | Sale | 1,710 | $84K | Form 4 |
| Jan 7, 2026 | Lizzul Paul F. Chief Medical Officer | Option | 8,525 | — | Form 4 |
| Jan 8, 2026 | Lizzul Paul F. Chief Medical Officer | Sale | 3,650 | $163K | Form 4 |
| Jan 7, 2026 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Option | 6,700 | — | Form 4 |
| Jan 8, 2026 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Sale | 2,515 | $112K | Form 4 |
| Jan 7, 2026 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Option | 5,888 | — | Form 4 |
Faga Daniel
President, CEO · Director
Date
Mar 27
Shares
510
Price
$56.61
Value
$29K
Faga Daniel
President, CEO · Director
Date
Mar 27
Shares
2,570
Price
$57.91
Value
$149K
Faga Daniel
President, CEO · Director
Date
Mar 27
Shares
3,662
Price
$58.62
Value
$215K
Faga Daniel
President, CEO · Director
Date
Mar 27
Shares
490
Price
$59.62
Value
$29K
Faga Daniel
President, CEO · Director
Date
Mar 27
Shares
550
Price
$60.63
Value
$33K
Faga Daniel
President, CEO · Director
Date
Mar 27
Shares
1,012
Price
$62.15
Value
$63K
Faga Daniel
President, CEO · Director
Date
Mar 27
Shares
2,592
Price
$63.35
Value
$164K
Faga Daniel
President, CEO · Director
Date
Mar 27
Shares
3,155
Price
$64.19
Value
$203K
Faga Daniel
President, CEO · Director
Date
Mar 27
Shares
3,038
Price
$65.20
Value
$198K
Faga Daniel
President, CEO · Director
Date
Mar 27
Shares
100
Price
$65.99
Value
$7K
LOUMEAU ERIC J
CHIEF LEGAL OFFICER
Date
Feb 11
Shares
10,000
Price
$29.70
Value
$297K
LOUMEAU ERIC J
CHIEF LEGAL OFFICER
Date
Feb 11
Shares
10,000
Price
$54.00
Value
$540K
Lizzul Paul F.
Chief Medical Officer
Date
Jan 8
Shares
3,650
Price
$44.71
Value
$163K
MULROY DENNIS
CHIEF FINANCIAL OFFICER
Date
Jan 8
Shares
2,515
Price
$44.71
Value
$112K
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About ANAB insider trading
ANAB insider trades
AnaptysBio, Inc. (ANAB) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Faga Daniel (President, CEO · Director), Schmid John P. (Director), LOUMEAU ERIC J (CHIEF LEGAL OFFICER). Over the past 12 months, 5 insiders have filed transactions with the SEC. ANAB insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For AnaptysBio, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
ANAB insider trading · 5 questionsThe insiders of AnaptysBio, Inc. (ANAB) include executives and directors such as Faga Daniel (President, CEO · Director), Schmid John P. (Director), LOUMEAU ERIC J (CHIEF LEGAL OFFICER), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026